RS55916B1 - Derivati aminociklobutana, metod za dobijanje istih i njihova upotreba kao lekova - Google Patents
Derivati aminociklobutana, metod za dobijanje istih i njihova upotreba kao lekovaInfo
- Publication number
- RS55916B1 RS55916B1 RS20170379A RSP20170379A RS55916B1 RS 55916 B1 RS55916 B1 RS 55916B1 RS 20170379 A RS20170379 A RS 20170379A RS P20170379 A RSP20170379 A RS P20170379A RS 55916 B1 RS55916 B1 RS 55916B1
- Authority
- RS
- Serbia
- Prior art keywords
- drugs
- preparing same
- aminocyclobutane
- derivatives
- aminocyclobutane derivatives
- Prior art date
Links
- KZZKOVLJUKWSKX-UHFFFAOYSA-N cyclobutanamine Chemical class NC1CCC1 KZZKOVLJUKWSKX-UHFFFAOYSA-N 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/14—Preparation of carboxylic acid amides by formation of carboxamide groups together with reactions not involving the carboxamide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/40—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/24—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/57—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and carboxyl groups, other than cyano groups, bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Dermatology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1261621A FR2998892B1 (fr) | 2012-12-04 | 2012-12-04 | Derives d'aminocyclobutane, leur procede de preparation et leur utilisation a titre de medicaments |
EP13811402.0A EP2928861B1 (fr) | 2012-12-04 | 2013-12-04 | Dérivés d'aminocyclobutane, leur procédé de préparation et leur utilisation à titre de médicaments |
PCT/EP2013/075481 WO2014086825A1 (fr) | 2012-12-04 | 2013-12-04 | Derives d'aminocyclobutane, leur procede de preparation et leur utilisation a titre de medicaments |
Publications (1)
Publication Number | Publication Date |
---|---|
RS55916B1 true RS55916B1 (sr) | 2017-09-29 |
Family
ID=48128432
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RS20170379A RS55916B1 (sr) | 2012-12-04 | 2013-12-04 | Derivati aminociklobutana, metod za dobijanje istih i njihova upotreba kao lekova |
Country Status (31)
Country | Link |
---|---|
US (2) | US9469601B2 (sr) |
EP (1) | EP2928861B1 (sr) |
JP (1) | JP6391586B2 (sr) |
KR (1) | KR102221928B1 (sr) |
CN (2) | CN106957285B (sr) |
AR (1) | AR093787A1 (sr) |
AU (1) | AU2013354133B2 (sr) |
BR (1) | BR112015012752B1 (sr) |
CA (1) | CA2893216C (sr) |
CY (1) | CY1118841T1 (sr) |
DK (1) | DK2928861T3 (sr) |
ES (1) | ES2621896T3 (sr) |
FR (1) | FR2998892B1 (sr) |
HK (1) | HK1212968A1 (sr) |
HR (1) | HRP20170564T1 (sr) |
IL (1) | IL239146A (sr) |
LT (1) | LT2928861T (sr) |
MA (1) | MA38229B1 (sr) |
MX (1) | MX364556B (sr) |
MY (1) | MY179886A (sr) |
NZ (1) | NZ709572A (sr) |
PL (1) | PL2928861T3 (sr) |
PT (1) | PT2928861T (sr) |
RS (1) | RS55916B1 (sr) |
RU (1) | RU2655919C2 (sr) |
SA (1) | SA515360518B1 (sr) |
SI (1) | SI2928861T1 (sr) |
TN (1) | TN2015000240A1 (sr) |
TW (1) | TWI603947B (sr) |
UA (1) | UA114017C2 (sr) |
WO (1) | WO2014086825A1 (sr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2019241765B2 (en) | 2018-03-28 | 2022-07-07 | Takeda Pharmaceutical Company Limited | Heterocyclic compound and use thereof |
JP2021050161A (ja) | 2019-09-25 | 2021-04-01 | 武田薬品工業株式会社 | 複素環化合物及びその用途 |
WO2021098732A1 (zh) * | 2019-11-18 | 2021-05-27 | 江苏恩华药业股份有限公司 | 一种1',2'-二氢-3'h-螺[环丁烷1,4'-异喹啉]-3'-酮衍生物及其应用 |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3133924A (en) * | 1960-05-31 | 1964-05-19 | Bristol Myers Co | Amino-substituted cyclobutane carboxamides |
FR2581059B1 (fr) * | 1985-04-25 | 1988-04-22 | Pf Medicament | Procede de preparation du chlorhydrate de phenyl-1 diethyl amino carbonyl-1 aminomethyl-2 cyclopropane (z) |
US5621142A (en) * | 1994-02-22 | 1997-04-15 | Asahi Kasei Kogyo Kabushiki Kaisha | Aminoalkylcyclopropane derivatives |
US6197830B1 (en) | 1995-09-22 | 2001-03-06 | Bruce M. Frome | Method for achieving relief from sympathetically mediated pain |
ES2241055T3 (es) | 1996-08-23 | 2005-10-16 | Endo Pharmaceuticals Inc | Composicion que contiene un anticonvulsionante para tratar el dolor neuropatico. |
DK1011658T3 (da) | 1997-09-08 | 2006-04-03 | Warner Lambert Co | Analgesiske præparater, der omfatter antiepileptiske forbindelser, og fremgangsmåder til anvendelse af samme |
US6172118B1 (en) * | 1998-04-14 | 2001-01-09 | Smithkline Beecham Corporation | Compounds |
CN1309562A (zh) | 1998-07-16 | 2001-08-22 | 纪念斯隆-凯特林癌症中心 | 包括一种阿片样物质镇痛剂和一种nmda拮抗剂的局部给药组合物 |
AU3386500A (en) | 1999-03-02 | 2000-09-21 | Merck & Co., Inc. | 3-cyclopropyl and 3-cyclobutyl pyrrolidine modulators of chemokine receptor activity |
US7820688B2 (en) | 2001-04-27 | 2010-10-26 | Memorial Sloan-Kettering Cancer Center | Topical anesthetic/opioid formulations and uses thereof |
AU2003210486B2 (en) | 2002-01-16 | 2007-06-28 | Endo Pharmaceuticals Inc. | Pharmaceutical composition and method for treating disorders of the central nervous system |
TW200307539A (en) * | 2002-02-01 | 2003-12-16 | Bristol Myers Squibb Co | Cycloalkyl inhibitors of potassium channel function |
US7687080B2 (en) | 2002-11-25 | 2010-03-30 | Taraxos Inc. | Treatment of neuropathy |
WO2006081179A1 (en) | 2005-01-25 | 2006-08-03 | Glaxo Group Limited | Antibacterial agents |
EP2121674B1 (en) | 2007-02-01 | 2010-05-12 | Tibotec Pharmaceuticals | Processes and intermediates for preparing a macrocyclic protease inhibitor of hcv |
US7638651B2 (en) * | 2007-04-26 | 2009-12-29 | Auspex Pharmaceuticals | Substituted cyclohexanones |
CN101896205A (zh) | 2007-08-27 | 2010-11-24 | 惠氏有限责任公司 | 使用nmda拮抗剂用于获得麻醉剂节约效果的组合物和方法 |
BRPI0819795B8 (pt) | 2007-11-28 | 2021-05-25 | Astellas Pharma Inc | compostos de indano fundidos e seus usos no tratamento de doenças relacionadas ao receptor nmda, bem como composição farmacêutica compreendendo os mesmos |
CN102066345B (zh) | 2008-01-16 | 2013-07-17 | 生物科技研究有限公司 | *唑烷衍生物作为nmda拮抗剂 |
CA2738468A1 (en) | 2008-09-27 | 2010-04-01 | Taraxos Inc. | Topical formulations for treatment of neuropathy |
TW201026667A (en) | 2008-09-30 | 2010-07-16 | Merz Pharma Gmbh & Co Kgaa | Glycine b antagonists |
FR2943666B1 (fr) | 2009-03-31 | 2011-04-15 | Commissariat Energie Atomique | Metallophore derive de nicotianamine et ses procedes de fabrication |
FR2944011B1 (fr) * | 2009-04-03 | 2011-05-20 | Pf Medicament | Derives d'aminocyclobutane ou d'aminocyclobutene, leur procede de preparation et leur utilisation a titre de medicaments. |
JP5745505B2 (ja) * | 2009-05-07 | 2015-07-08 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | バニロイド受容体リガンドとしての置換フェニル尿素および置換フェニルアミド |
FR2946535B1 (fr) | 2009-06-10 | 2011-09-09 | Neureva | Composition comprenant une molecule favorisant l'interaction neurone-glie, notamment pour prevenir la formation de la cicatrice gliale et induire la regeneration neurale. |
TWI544923B (zh) | 2009-12-29 | 2016-08-11 | 何應瑞 | 用於治療神經退化性疾病之醫藥組合物 |
-
2012
- 2012-12-04 FR FR1261621A patent/FR2998892B1/fr not_active Expired - Fee Related
-
2013
- 2013-12-03 TW TW102144198A patent/TWI603947B/zh not_active IP Right Cessation
- 2013-12-04 UA UAA201506431A patent/UA114017C2/uk unknown
- 2013-12-04 NZ NZ709572A patent/NZ709572A/en not_active IP Right Cessation
- 2013-12-04 DK DK13811402.0T patent/DK2928861T3/en active
- 2013-12-04 JP JP2015545991A patent/JP6391586B2/ja active Active
- 2013-12-04 CN CN201710102368.2A patent/CN106957285B/zh not_active Expired - Fee Related
- 2013-12-04 PL PL13811402T patent/PL2928861T3/pl unknown
- 2013-12-04 MA MA38229A patent/MA38229B1/fr unknown
- 2013-12-04 KR KR1020157017845A patent/KR102221928B1/ko active IP Right Grant
- 2013-12-04 US US14/649,448 patent/US9469601B2/en active Active
- 2013-12-04 AR ARP130104484A patent/AR093787A1/es not_active Application Discontinuation
- 2013-12-04 WO PCT/EP2013/075481 patent/WO2014086825A1/fr active Application Filing
- 2013-12-04 ES ES13811402.0T patent/ES2621896T3/es active Active
- 2013-12-04 RS RS20170379A patent/RS55916B1/sr unknown
- 2013-12-04 CN CN201380063117.8A patent/CN104854083B/zh not_active Expired - Fee Related
- 2013-12-04 MX MX2015006686A patent/MX364556B/es active IP Right Grant
- 2013-12-04 CA CA2893216A patent/CA2893216C/fr active Active
- 2013-12-04 PT PT138114020T patent/PT2928861T/pt unknown
- 2013-12-04 LT LTEP13811402.0T patent/LT2928861T/lt unknown
- 2013-12-04 EP EP13811402.0A patent/EP2928861B1/fr active Active
- 2013-12-04 AU AU2013354133A patent/AU2013354133B2/en not_active Ceased
- 2013-12-04 BR BR112015012752-5A patent/BR112015012752B1/pt not_active IP Right Cessation
- 2013-12-04 RU RU2015126104A patent/RU2655919C2/ru active
- 2013-12-04 SI SI201330607A patent/SI2928861T1/sl unknown
- 2013-12-04 MY MYPI2015701784A patent/MY179886A/en unknown
-
2015
- 2015-06-02 TN TNP2015000240A patent/TN2015000240A1/fr unknown
- 2015-06-02 IL IL239146A patent/IL239146A/en active IP Right Grant
- 2015-06-03 SA SA515360518A patent/SA515360518B1/ar unknown
-
2016
- 2016-01-29 HK HK16101031.1A patent/HK1212968A1/zh not_active IP Right Cessation
- 2016-09-12 US US15/262,885 patent/US9687459B2/en active Active
-
2017
- 2017-04-06 CY CY20171100409T patent/CY1118841T1/el unknown
- 2017-04-10 HR HRP20170564TT patent/HRP20170564T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1203507A1 (en) | New indolizine derivatives, method for preparing same and pharmaceutical compositions containing same | |
ZA201404625B (en) | Polycyclic derivatives, preparation method and medical uses thereof | |
HK1248214A1 (zh) | 新噻吩並嘧啶衍生物、其製備方法及其治療用途 | |
EP2881395A4 (en) | PIPERAZINOTRIZOLE COMPOUND, PROCESS FOR PREPARING THE SAME AND USE THEREOF IN THE PREPARATION OF MEDICAMENT | |
IL245101B (en) | Derivatives of 1,4-cyclohexylamine and processes for their preparation | |
EP2742020A4 (en) | N1-CYCLIC AMIN-N5-SUBSTITUTED BIGUANIDE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITION THEREWITH | |
HK1211849A1 (en) | Combination drug comprising gemigliptin and metformin, and method for the preparation thereof | |
EP2924042A4 (en) | BIS-BETA-CARBOLINE COMPOUND AND METHOD OF MANUFACTURING, PHARMACEUTICAL COMPOSITION AND USE THEREOF | |
EP2813495A4 (en) | 2-ARYLBENZOFURAN-7-FORMAMIDE COMPOUNDS, PROCESS FOR THEIR PREPARATION AND USE THEREOF | |
EP2837627A4 (en) | AMIDOPYRIDINE DERIVATIVE AND USE THEREOF | |
EP2865666A4 (en) | HEXAHYDROPENTALENE DERIVATIVES, METHOD OF MANUFACTURE AND USE IN MEDICINE | |
EP2805954A4 (en) | 7-SUBSTITUTED HANFANGICHIN B DERIVATIVE AND MANUFACTURING METHOD AND USE THEREOF | |
ZA201309559B (en) | Comptothecin derivative, method for preparing same, pharmaceutical composition and use thereof | |
EP2805956A4 (en) | GAMBOGIC ACID DERIVATIVES, PREPARATION METHOD AND APPLICATION THEREOF | |
EP3078659A4 (en) | 3-FURYL-2-CYANO-2-ACRYLAMIDE DERIVATIVE, PROCESS FOR PREPARING THE SAME, PHARMACEUTICAL COMPOSITION AND USE THEREOF | |
HK1212968A1 (zh) | 氨基環丁烷衍生物、其製備方法及其用作藥物的用途 | |
HUE050104T2 (hu) | 3,5N-trihidroxi-alkánamid és származékok: eljárás ennek elõállítására és ennek felhasználása | |
IL227544A0 (en) | Leoplomide and its enantiomers, a method for their preparation and medical uses thereof | |
AP3759A (en) | Method for preparing phenyloxymethyl-nitro-imidazole derivatives and use of the same | |
EP2889292A4 (en) | 2-SUBSTITUTED 2H-1,2,3-TRIAZOLE DERIVATIVE AND METHOD OF MANUFACTURING THEREOF | |
PL398018A1 (pl) | Nowa diacylo-sn-glicero-3-fosfocholina oraz sposób jej otrzymywania | |
PL398021A1 (pl) | Nowa diacylo-sn-glicero-3-fosfocholina oraz sposób jej otrzymywania | |
HUP1300393A2 (en) | Quinazoline derivatives, process for the preparation thereof and pharmaceutical compositions comprising the same | |
PL398987A1 (pl) | (Z)-6-siarczan-6,4'-dihydroksy-7-prenylo-4-metoksyauronu i sposób jego wytwarzania |